Does OBINUTUZUMAB Cause Disease progression? 831 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 831 reports of Disease progression have been filed in association with OBINUTUZUMAB (Gazyva). This represents 5.9% of all adverse event reports for OBINUTUZUMAB.
831
Reports of Disease progression with OBINUTUZUMAB
5.9%
of all OBINUTUZUMAB reports
184
Deaths
75
Hospitalizations
How Dangerous Is Disease progression From OBINUTUZUMAB?
Of the 831 reports, 184 (22.1%) resulted in death, 75 (9.0%) required hospitalization, and 9 (1.1%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for OBINUTUZUMAB.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
Atrial fibrillation (548)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which OBINUTUZUMAB Alternatives Have Lower Disease progression Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE